Publications by authors named "T F Boerner"
Background: COVID-19 increased the burden of childcare on parents, leaving women vulnerable to increased disparities in the division of domestic labor. Women healthcare workers may be at heightened risk of worsening gender parity in the workplace as a result.
Objective: To examine the impact of the COVID-19 pandemic on gender parity in the division of household responsibilities among women healthcare workers.
Objective: Evaluate an electronic platform for remote symptom monitoring to enhance postdischarge care in thoracic surgery using patient reporting of symptoms.
Summary Background Data: Owing to the increased use of enhanced recovery after surgery protocols, patients are spending a larger portion of their postoperative course at home. For patients undergoing complex operations, this represents an opportunity for early identification of abnormal symptoms at home before deterioration.
Esophagectomy may have a role in stage IV esophageal adenocarcinoma.
J Thorac Cardiovasc Surg
November 2024
Objective: We sought to determine whether aggressive local treatment provides a benefit in patients with stage IV esophageal adenocarcinoma and to determine factors associated with survival.
Methods: Patients with clinical stage IV esophageal adenocarcinoma at diagnosis who underwent esophagectomy from 2010 to 2023 were identified from our prospectively maintained database. Clinicopathologic and demographic characteristics were compared among patients by stage.
Article Synopsis
- The study examined the relationship between preoperative frailty and outcomes in older patients (65+) undergoing esophagectomy, rather than just focusing on age.
- Using a frailty scoring system called MSK-FI, researchers analyzed 447 patients and found that higher frailty scores were linked to increased risks of major complications, readmissions, and being discharged to a facility after surgery.
- Although frailty was a strong indicator of short-term morbidity, it did not correlate with 90-day mortality, suggesting it can help identify patients at higher risk for complications during surgery decision-making.
Background: To date, only two studies have compared the outcomes of patients with liver-limited BRAF V600E-mutated colorectal liver metastases (CRLMs) managed with resection versus systemic therapy alone, and these have reported contradictory findings.
Methods: In this observational, international, multicentre study, patients with liver-limited BRAF V600E-mutated CRLMs treated with resection or systemic therapy alone were identified from institutional databases. Patterns of recurrence/progression and overall survival were compared using multivariable analyses of the entire cohort and a propensity score-matched cohort.